The Goal of Every H1N1 Swine Flu Vaccine: Immunotoxicity, Neurotoxicity and Sterility

Prevent Disease
October 30, 2009
 
Science dictates that only a randomized double-blind, placebo-controlled study can generate unbiased results in any clinical trial. In the history of vaccine development, no such study has ever been performed. It is only unscientific opinions and pharmaceutical propaganda which have propelled the mythological validity, safety and effectiveness of vaccines. Dozens of controlled studies have scientifically verified the immunotoxicty, neurotoxicity and sterility of common vaccine ingredients which destroy human health, yet they are all ignored by conventional medicine.
 
There should be a public outcry and challenge to every public health official, medical specialist or scientist (from any country) who justifies the inoculation of their population without providing the evidence of safety and effectiveness of the respective H1N1 vaccine in their country.

The public should be demanding that their governments materialize at least one vaccine trial which is randomized, double-blind and placebo-controlled that can scientifically validate the assertions of public health officials.

Since the pharmacokinetic properties of vaccines are not studied, vaccine manufacturers cannot deny any of the toxic effects listed below. The reason they never analyze the absorption, distribution, metabolism or excretion of these ingredients is because it would eradicate the vaccine industry. However the individual effects of each ingredient and their toxic effects on cells are well documented.

Every Physician, Nurse or medical personnel who administers the H1N1 vaccine (or any vaccine) should be asking themselves why they are injecting the following ingredients into patients that have been scientifically proven to cause immunotoxicity, neurotoxicity, sterility and cancer:

Novartis Focetria Adjuvanted H1N1

Influenza Vaccine Ingredients/Toxicity

Polysorbate 80: Sterilie Agent

Potassium Chloride: Neurotoxin

Squalene: Neurotoxin

Thimerosal: Neurotoxin

Novartis H1N1 Monovalent Influenza Vaccine Ingredients/Toxicity

Beta-Propiolactone: Carcinogen

Polymyxin: Neurotoxin

Neomycin: Immunotoxin

Thimerosal: Neurotoxin

GlaxoSmithKline Arepanrix Adjuvanted

H1N1 Influenza Vaccine Ingredients/Toxicity

Formaldehyde: Carcinogen

Polysorbate 80: Sterilie Agent

Sodium Deoxycholate: Immunotoxin

Squalene: Neurotoxin

Thimerosal: Neurotoxin

GlaxoSmithKline Pandemrix Adjuvanted

H1N1 Influenza Vaccine Ingredients/Toxicity

Octoxynol 10: Immunotoxin

Polysorbate 80: Sterilie Agent

Potassium Chloride: Neurotoxin

Sodium Deoxycholate: Immunotoxin

Squalene: Neurotoxin

Thimerosal: Neurotoxin

GlaxoSmithKline Fluarix 2009-2010

Formula Ingredients/Toxicity

Formaldehyde: Carcinogen

Octoxynol 10: Immunotoxin

Polysorbate 80: Sterilie Agent

Sodium Deoxycholate: Immunotoxin

Sanofi-Pasteur H1N1 Influenza Vaccine Ingredients/Toxicity

Formaldehyde: Carcinogen

Polyethylene Glycol: Systemic Toxin

Thimerosal: Neurotoxin

MedImmune H1N1 Vaccine Ingredients/Toxicity

Monosodium Glutamate: Neurotoxin

Gentamicin Sulfate: Nephrotoxin

Monobasic Potassium Phosphate: Immunotoxin

FLUARIX 2009 Latest Package Insert Ingredients/Toxicity

Formaldehyde: Carcinogen

Gentamicin Sulfate: Nephrotoxic

Polysorbate 80: Sterilie Agent

Sodium Deoxycholate: Immunotoxin

Thimerosal: Neurotoxin

CSL PANVAX H1N1 Vaccine Ingredients/Toxicity

Beta-Propiolactone: Carcinogen

Neomycin: Immunotoxin

Sodium Taurodeoxycholate: Carcinogen/Immunotoxin

Polymyxin: Neurotoxin

Thimerosal: Neurotoxin

CSL Afluria H1N1 Influenza Vaccine Ingredients/Toxicity

Beta-Propiolactone: Carcinogen

Neomycin Sulfate: Immunotoxin

Polymyxin B: Neurotoxin

Potassium Chloride: Neurotoxin

Sodium Taurodeoxycholate: Carcinogen/Immunotoxin

Thimerosal: Neurotoxin

Note: An additional CSL H1N1 Vaccine is Undergoing Trials with AS03 Adjuvant which contains Squalene.

Adverse Reactions of Vaccines

Serious adverse reactions are as follows:

* Pain

* Redness

* Swelling

* Fatigue

* Headaches

* Arthralgia (joint inflammation)

* Myalgia (muscle inflammation)

* Shivering

* Sweating

* Swollen lymph nodes

* Fever

* Vomiting

* Tingling or numbness of the hands or feet

* Shortness of breath

* Vasculitis (inflammation of the blood vessels)

* Blood and lymphatic system disorders (lymphadenopathy)

* Psychiatric disorders (insomnia)

* Nervous system disorders (dizziness, paraesthesia, inflammation of the central nervous system, inflammation of nerves, autoimmune disorders affecting myelin sheaths of nerves such as Guillain-Barré Syndrome)

* Ear and labyrinth disorders (vertigo)

* Respiratory, thoracic and mediastinal disorders (dyspnoea)

* Gastrointestinal disorders (nausea, diarrhea, abdominal pain, vomiting, dyspepsia, stomach discomfort)

* Skin and subcutaneous tissue disorders (pruritus, rash)

* Musculoskeletal and connective tissue disorders (back pain, musculoskeletal stiffness, neck pain, muscle spasms, pain in extremity)

* General disorders and administration site conditions (bruising, asthenia, chest pain, malaise)